This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Wildfires Have Significant Impacts on Respiratory Health Laura Stiles June 9th 2025 Article There were more fires in the span of a 13-year period from 2005 to 2018 than in the previous 2 decades. McKesson ideaShare: Wrapping Up The Week June 25th 2023 Podcast Drug Topics wraps up a great week in Las Vegas at McKesson ideaShare.
Wildfires Have Significant Impacts on Respiratory Health Laura Stiles June 9th 2025 Article There were more fires in the span of a 13-year period from 2005 to 2018 than in the previous 2 decades.
December 2018. link] articles/2018/12/dysmenorrhea-and-endometriosis-in-the-adolescent 4. American Pharmaceutical Association; 2025. Dysmenorrhea and endometriosis in the adolescent. American College of Obstetricians and Gynecologists. Accessed April 28, 2025. Smith RP, Kaunitz AM. UpToDate.
2018 ESC/ESH guidelines for the management of arterial hypertension. 2018; 39: 3021–3104. Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71:e127-e248. doi:10.1016/j.jacc.2017.11.006 2017.11.006 Williams B, Mancia G, Spiering W, et al. Eur Heart J.
December 13, 2018. American Oncology Network. August 8, 2024. Accessed May 15, 2025. How your oncology peers manage the complexities of care. Oncology Live ®. Accessed May 15, 2025. Desimone R. Improve work performance with a focus on employee development. December 12, 2019. Updated January 19, 2024. Accessed May 15, 2025.
August 24, 2018. Additionally, like all NSAIDs, meloxicam injection should be used with caution in patients with cardiovascular, gastrointestinal, or renal risk factors. 2 REFERENCES 1. Schwenk E, Mariano E, et al. Designing the ideal perioperative pain management plan starts with multimodal analgesia. Korean Journal of Anesthesiology.
These diseases are caused by a dysregulated mucosal immune response to the intestinal microflora in hosts who are genetically predisposed. That same year, approximately 88% of the evaluated ImproveCareNow (ICN) Network centers were observed to be using biosimilars.
Thus, the reduced number of newly licensed pharmacists versus PharmD graduates: 2 In 2018, there were 14,905 PharmD graduates and 14,103 taking the NAPLEX for the first time. " 1 The downward trend in US PharmD graduates continues, as does the reduction in those taking the North American Pharmacist Licensure Examination (NAPLEX).
She hesitated, and I took her into our immunization room. She admitted she was using them for injection drug use, and I gave her 5 syringes we were using for COVID-19 vaccine injections that were provided by the government. She was most grateful and assured me she was going to seek help the next day.
031), and diagnosis between 2016 and 2018 (OR 1.93, P < 001) as well as 2019 and 2020 (1.88, P < 001). in 2016, representing a period of rapid uptake—and usage was consistently high from 2016 to 2018. 3 The utilization of HER2 therapies increased from 64.6% in 2013 to 80.9%
link] Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry, January 2018. Updated May 6, 2020. Accessed June 9, 2025. link] FDA Drug Shortages. Updated December 19, 2024. Accessed June 9, 2025.
cancer and vaccines), and non-immunogenic applications (e.g., cancer and vaccines), and non-immunogenic applications (e.g., Several types of mRNA-based vaccines have emerged, namely non-replicating linear mRNAs (NRM), self-amplifying mRNAs (saRNAs), and circular mRNAs (circRNAs). Types of messenger RNA (mRNA)-based vaccines.
Research from the University of Colorado Boulder found that there were more fires in the span of a 13-year period from 2005 to 2018 than in the previous 2 decades, with fire frequency doubling on the East and West coasts and quadrupling in the Great Plains regions. describes airborne particles with a diameter of 2.5
link] Recent Videos Related Content Wildfires Have Significant Impacts on Respiratory Health Laura Stiles June 9th 2025 Article There were more fires in the span of a 13-year period from 2005 to 2018 than in the previous 2 decades.
Patients with dilated cardiomyopathy (DCM) or controls with normal cardiac MRI findings from January 2018 to December 2022 were included. is associated with diffuse myocardial fibrosis, a precursor to heart failure, as shown by increased native T1 z-scores in cardiac MRI. µm or smaller aerodynamic diameter (PM2.5)—which
Sanofi and Translate Bio have started a first clinical trial of an mRNA-based seasonal flu vaccine, adding to the COVID-19 shot already in testing as part of their three-year old collaboration. Sanofi and Translate have been working together since 2018, when they agreed to develop mRNA vaccines for up to five infectious diseases.
German pharmaceutical firm Merck has extended its partnership with Moderna to jointly develop and sell mRNA-4157/V940, an investigational personalised cancer vaccine (PCV). They subsequently expanded the collaboration to include the development of antigen mRNA cancer vaccines in 2018.
Biotech Vaxxas has announced a partnership agreement with the 2017-established Coalition for Epidemic Preparedness Innovations (CEPI), in order to advance the development of Vaxxas’ needle-free vaccine-patch delivery technology with preclinical testing of an mRNA vaccine patch. The agreement, worth $4.3 The agreement, worth $4.3
The Japanese Ministry of Health, Labour and Welfare (MHLW) has accepted GlaxoSmithKline’s (GSK) regulatory application for recombinant, adjuvanted Zoster vaccine, Shingrix, for preventing shingles (herpes zoster) in at-risk adults of the age 18 years and above.
The mRNA technology that was deployed so effectively in vaccines against COVID-19 has now been found to offer similar promise against cancer, according to Merck & Co and Moderna. The vaccine primes the immune system to attack the tumour cells, while Keytruda blocks an immunological ‘brake’ that protects the cancer.
Since the first human administration of the Bacillus Calmette-Guérin vaccine in 1921, no one has been able to successfully follow the vaccine’s path to become the next approved vaccine to tackle tuberculosis (TB). However, as the TB-related death toll remains high, the global need for another vaccine is steadily rising.
Rinvoq works by lowering your immune system activity,” said Joanne Nguyen, Pharm.D. , By suppressing a specific pathway in the immune system, Rinvoq reduces inflammation and relieves symptoms associated with inflammatory conditions. The studies, called Measure Up 1 and Measure Up 2 , took place from 2018 to 2020.
Immunotherapies can compromise the diversity and complex interactive networks in the microbial ecosystem and therefore play a role in activating or deactivating the patient’s immune response leading to variable outcomes of melanoma treatment. Science 2018 Available from: [link] Davar D. Internet] European Commission. cited 2023June].
It inhibits the body’s immune system response, decreasing the inflammation and discomfort associated with gout. For example, because it reduces immune resistance, it could make you more susceptible to infection. It might work quickly, too. Some people may feel some relief within an hour.
Stock Exchange: TYO With focus areas extending to the discovery and development of biopharma products, AnGes is dedicated to developing genetic medicines and therapeutic vaccines for intractable or rare diseases. Kymriah was approved by the EMA (Aug 2018), Health Canada (Sep 2018), TGA (Dec 2018), MHLW (Mar 2019), and the US FDA (May 2022).
SARS-CoV-2 is likely to stay endemic in the human population for the foreseeable future, ExeVir noted, with variants capable of evading immunity the most likely cause of the disease in the future as global vaccination programmes begin to take effect. ExeVir is not the first company to spin out of VIB to focus on camelid antibodies.
Founded Year: 2018 Total Employees: ~80 Headquarters: California, United States Market Cap: $43.1M Through its internal development, partnerships, and acquisitions, the company has put together four technology platforms that primarily focus on antibodies, T cells, innate immunity, and siRNAs. R&D Expenditure: $85.1M
CAR-Ts can sometimes cause cytokine release syndrome (CRS), when the immune system goes into overdrive and causes dangerous inflammation, which means patients have to receive prophylactic immune-suppressing drugs that can limit the efficacy of treatment.
Latest data shows that non-COVID studies are restarting after being put on hold while many companies turned their attention to developing vaccines or therapies to counter the pandemic. Cancer remains the top area for UK clinical trials with 226 trials taking place in 2018, with research on the immune system coming next with 94 trials.
The success of mRNA vaccines against SARS-CoV-2 has quickly catapulted mRNA therapeutics as a disruptive, expanding drug category” The term ‘mRNA’ has become commonplace globally. The success of mRNA vaccines against SARS-CoV-2 has quickly catapulted mRNA therapeutics as a disruptive, expanding drug category.
billion in 2018, after its first attempt to seek approval from the FDA was turned down due to manufacturing issues identified at a third-party manufacturer of the drug. It is also being developed for other indications including immune thrombocytopenic purpura. g/dl and preventing blood transfusions between weeks five and 26.
He was responsible for the national immunisation programme and led the introduction of many new vaccines. He previously chaired the WHO’s Strategic Advisory Group of Experts on Immunization, the WHO committee that sets global immunisation policy. OVID was founded in 2018 by ex-Lib Dem health adviser and agency leader Jenny Ousbey.
It may occur in people over the age of 50 or people of any age with a compromised immune system. You can also get a vaccine called Shingrix to help reduce the risk of shingles infection if you are 50 or older—or if you are 19 or older with a higher risk of infection. VZV is the same virus that causes varicella, or chickenpox.
The company’s product portfolio comprises two platforms: Virax Immune, a new-Covid-19 test detecting the T-Cell immune response to the SARS-Cov-2 virus and ViraxClear, a platform to sell a range of highly accurate diagnostic test kits and machines. Founded Year: 2018 No. Founded Year: 2018 No. Founded Year: 2018 No.
BioNTech has found a use for some of the windfall cash it has raked in from its COVID-19 vaccine, agreeing a deal to buy Kite Pharma’s entire neoantigen T cell receptor (TCR) platform for solid tumours, and an associated manufacturing plant. BioNTech’s first quarter revenues came in at more than €2 billion ($2.4
Birthplace: Belén was born in Almansa (Spain) Additional Information: Merck became a significant international participant in immunology, oncology, and immune oncology under her leadership of the Healthcare business. Designation: Global Head Previous company: Merck Global Vaccines (2 yrs. and Banco Bilbao Vizcaya Argentaria S.A
The company develops mRNA therapeutics and vaccines , and the move will enable it to utilise the synthetic biology and enzyme tech of 2018-founded Japanese company OriCiro, which develops cell-free DNA synthesis and amplification technologies, and thereby expand Moderna’s portfolio. Biotech Moderna, Inc. and OriCiro Genomics K.K.
Demand for biologics, including vaccines, is at an all-time high, in the post-Covid era. There are fewer sites for cell and gene therapies and vaccines – 90 companies with 127 facilities, as per GlobalData figures. The approval of the mRNA Covid-19 vaccine, which is a biologic, has thrust the modality even further into the spotlight.
The arrival of COVID-19 brought precious few positives, but one that emerged for the pharmaceutical industry was the emergence and validation of mRNA vaccine technology to prevent disease. Pfizer already has a head start on competitors in the field, having achieved the first US FDA approval for an mRNA vaccine, alongside BioNTech.
Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA vaccines against COVID-19. But the tragic events of 2020 have meant these companies have become household names as their trailblazing mRNA vaccines became the first to be approved by regulators against the COVID-19 scourge.
Dr Jennifer Harbottle, senior scientist in the R&D Base Editing team of PerkinElmer’s Horizon Discovery business, looks at progress made in the realms of biotechnology and next-generation diagnostics, vaccines and therapeutics, including the application of CRISPR-Cas9 gene editing in developing and refining cell therapies.
The conference focused on the ongoing development and growth in these technologies, and featured speakers on a broad range of topics, including advanced manufacturing and how lessons learned from COVID-19 vaccine development can apply to biologics development. Also having enough glass vials to put the vaccines in!
These biopharmaceuticals encompass a range of products including vaccines, recombinant therapeutic proteins, tissues, cells and gene therapies – all sourced from living organisms. The emergency use approval from the FDA of lipid nanoparticle- (LNP-) based mRNA vaccines during the COVID-19 pandemic attested the significance of LNPs.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content